Holen Sie sich die Stockscreener-App
1.77
1.72%
0.03
Handel nachbörslich:
1.75
-0.02
-1.13%
Schlusskurs vom Vortag:
$1.74
Offen:
$1.7
24-Stunden-Volumen:
169.35K
Relative Volume:
0.63
Marktkapitalisierung:
$55.39M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-25.94M
KGV:
-1.2826
EPS:
-1.38
Netto-Cashflow:
$-15.79M
1W Leistung:
-5.35%
1M Leistung:
-0.56%
6M Leistung:
-15.31%
1J Leistung:
-46.85%
1-Tages-Spanne:
$1.70
$1.8023
1-Wochen-Bereich:
$1.60
$1.86
52-Wochen-Spanne:
$1.40
$4.24
MAIA Biotechnology Inc Stock (MAIA) Company Profile
Firmenname
MAIA Biotechnology Inc
Sektor
Branche
Telefon
312 416 8592
Adresse
444 West Lake Street, Suite 1700, Chicago
Vergleichen Sie MAIA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MAIA
MAIA Biotechnology Inc
|
1.77 | 55.39M | 0 | -25.94M | -15.79M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.30 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
521.00 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.83 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
560.14 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
241.20 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
MAIA Biotechnology Inc Aktie (MAIA) Neueste Nachrichten
MAIA Biotechnology partners with Roche for cancer treatment studies By Investing.com - Investing.com South Africa
Maia Biotechnology Signs Clinical Supply Deal With Roche; Shares Rise - MarketScreener
MAIA Biotech (MAIA) Partners with Roche for Cancer Treatment Study - GuruFocus
MAIA Biotechnology, Inc. Announces Master Clinical Supply Agreement with Roche for Hard-To-Treat Cancer Therapies - marketscreener.com
MAIA Biotechnology in pact with Roche for cancer treatments - Seeking Alpha
MAIA Biotechnology partners with Roche for cancer treatment studies - Investing.com
MAIA Biotechnology Announces Master Clinical Supply Agreement with Roche for Hard-to-Treat Cancer Therapies - BioSpace
MAIA Biotechnology Announces Agreement with Roche - TipRanks
MAIA Biotechnology Enters Inducement Offer Agreements - TipRanks
Short Interest in MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Declines By 35.8% - Defense World
MAIA Biotechnology to Present at BIO International Convention 2025 - BioSpace
Jane Street Group LLC Makes New Investment in MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) - Defense World
MAIA Biotechnology Reports Positive Phase 2 Trial Results - TipRanks
Why Is MAIA Biotechnology Stock Trading Higher On Thursday?MAIA Biotechnology (AMEX:MAIA) - Benzinga
MAIA Biotechnology's Promising Results in Lung Cancer Trial | MA - GuruFocus
MAIA Biotechnology's Promising Results in Lung Cancer Trial | MAIA Stock News - GuruFocus
MAIA Biotechnology Says New Responder In Non-Small Cell Lung Cancer Phase 2 Clinical Trial - marketscreener.com
MAIA Biotechnology Announces New Responder in Non-Small Cell Lung Cancer Phase 2 Clinical Trial - Business Wire
MAIA Biotechnology Announces Positive Efficacy Update for Phase 2 THIO-101 Clinical Trial in Non-Small Cell Lung Cancer - BioSpace
MAIA Biotechnology Reports Promising Results from THIO-101 Phase 2 Trial | MAIA Stock News - GuruFocus
Maia Biotechnology Says Ateganosine Treatment Extends Median Overall Survival in Lung Cancer Study - marketscreener.com
Maia Biotechnology stock rises following positive trial results By Investing.com - Investing.com Nigeria
Maia Biotechnology stock rises following positive trial results - Investing.com Australia
MAIA Biotechnology Showcases Promising THIO-101 Trial Data - TipRanks
MAIA Biotechnology Announces Private Placement Agreement - TipRanks
MAIA Biotechnology (NYSEAMERICAN:MAIA) Trading 4.1% Higher – Still a Buy? - Defense World
MAIA Biotechnology secures $669,500 in private placement By Investing.com - Investing.com South Africa
MAIA Biotechnology Announces Private Placement of Approximately $669,500 - BioSpace
MAIA Biotechnology, Inc. (MAIA) Raises $695K in Private Placement to Advance Cancer Trial - Yahoo
CORRECTING and REPLACING MAIA Biotechnology Announces Private Placement of Approximately $695,000 - BioSpace
MAIA Biotechnology secures $669,500 in private placement - Investing.com
MAIA Biotechnology doubles authorized shares - Investing.com Australia
MAIA Biotechnology doubles authorized shares By Investing.com - Investing.com South Africa
MAIA Biotechnology Increases Authorized Common Stock Shares - TipRanks
MAIA Biotechnology Approves Key Changes at Annual Meeting - TipRanks
MAIA Biotechnology Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2025 Annual Meeting - Business Wire
MAIA Biotechnology Announces Director Participation in Recent Private Placement - Business Wire
Best Momentum Stocks to Buy for May 6th - The Globe and Mail
MAIA Biotechnology Raises $1.08M in Private Placement - TipRanks
MAIA Biotechnology launches $1.08M private placement - MSN
CORRECTION: MAIA Biotechnology Announces $1.08 Million Private Placement - Business Wire
MAIA Biotechnology secures $1.08 million in private placement By Investing.com - Investing.com Canada
Maia Biotechnology Announces $1.08 Million Private Placement - marketscreener.com
MAIA Biotechnology secures $1.08 million in private placement - Investing.com
MAIA Biotechnology Raises $1.08M at $1.50 Per Share to Advance Phase II Cancer Trial - Stock Titan
Finanzdaten der MAIA Biotechnology Inc-Aktie (MAIA)
Umsatz
Nettogewinn
Free Cashflow
ENV
MAIA Biotechnology Inc-Aktie (MAIA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Guerrero Ramiro | Director |
May 08 '25 |
Buy |
1.50 |
20,000 |
30,000 |
588,218 |
| Smith Stan | Director |
May 08 '25 |
Buy |
1.50 |
66,666 |
99,999 |
1,271,726 |
| Guerrero Ramiro | Director |
Mar 03 '25 |
Buy |
1.50 |
33,333 |
50,000 |
568,218 |
| Smith Stan | Director |
Mar 03 '25 |
Buy |
1.50 |
25,000 |
37,500 |
1,205,060 |
| Guerrero Ramiro | Director |
Feb 24 '25 |
Buy |
1.50 |
73,333 |
110,000 |
534,885 |
| Smith Stan | Director |
Feb 24 '25 |
Buy |
1.50 |
50,000 |
75,000 |
1,180,060 |
| Smith Stan | Director |
Dec 13 '24 |
Buy |
1.87 |
25,000 |
46,800 |
1,130,060 |
| Guerrero Ramiro | Director |
Dec 13 '24 |
Buy |
1.87 |
53,418 |
99,998 |
514,970 |
| Luput Cristian | Director |
Nov 01 '24 |
Buy |
2.51 |
22,133 |
55,554 |
389,483 |
| CHAOUKI STEVEN M | Director |
Nov 01 '24 |
Buy |
2.51 |
22,133 |
55,554 |
111,024 |
1.11%
1.70%
Kapitalisierung:
|
Volumen (24h):